Recent News for DPLO - Diplomat Pharmacy, Inc.

Date Title
Aug 14 Diplomat Pharmacy Considers Its Options
Aug 11 Edited Transcript of DPLO earnings conference call or presentation 9-Aug-19 12:30pm GMT
Aug 9 Diplomat Pharmacy Inc (DPLO) Q2 2019 Earnings Call Transcript
Aug 9 Diplomat Pharmacy, Inc. -- Moody's downgrades Diplomat Pharmacy to B3; outlook developing
Aug 9 Diplomat Pharmacy's (DPLO) CEO Brian Griffin on Q2 2019 Results - Earnings Call Transcript
Aug 9 Diplomat Pharmacy, Inc. 2019 Q2 - Results - Earnings Call Slides
Aug 9 Diplomat Pharmacy up 5% premarket on revenue beat
Aug 9 Diplomat Pharmacy's stock climbs after potential sale considered as it reported a wider loss
Aug 9 Diplomat Pharmacy Reports Q2 Earnings Beat, Will Explore Strategic Alternatives
Aug 9 Diplomat Pharmacy EPS misses by $1.94, beats on revenue
Aug 9 Diplomat Announces 2nd Quarter Financial Results; Updates 2019 Guidance
Aug 9 Diplomat Announces Review of Strategic Alternatives
Aug 9 The Daily Biotech Pulse: Vascepa Delay Sends Amarin Reeling, Eidos Jumps On Buyout Offer, Nektar's Bitter Q2
Aug 9 Earnings Scheduled For August 9, 2019
Aug 8 Diplomat Pharmacy Q2 2019 Earnings Preview
Aug 8 Diplomat signs exclusive practice-based infusion agreement with Allergy Partners
Aug 8 Diplomat Pharmacy's Q2 Earnings Preview
Aug 3 The Week Ahead In Biotech: Focus On Earnings Deluge, Mid-Year Clinical Trial Readouts
Aug 2 Analysts Estimate Diplomat Pharmaceuticals (DPLO) to Report a Decline in Earnings: What to Look Out for
Aug 1 Is Diplomat Pharmacy, Inc. (NYSE:DPLO) Trading At A 41% Discount?
Jul 18 Diplomat to Release Second-Quarter 2019 Operating Results August 9
Jul 15 (DPLO) Alert: Johnson Fistel, LLP Announces Investigation of Diplomat Pharmacy, Inc.; Long Term Investors Encouraged to Contact Firm
Jul 11 Healthcare dominate premarket gainers
Jul 9 Diplomat Launches Empower Ecosystem Patient Support Digital Library
Jun 27 Rite Aid (RAD) Incurs Loss in Q1, Revenues Decline Y/Y
Back to the Main DPLO Page...